Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Insmed, Inc.
Pharmaceutical Preparations NJ, United States
Nasdaq: INSM
Company Description
Insmed, Inc. is a development stage biopharmaceutical company with expertise in proprietary, advanced liposomal technology designed specifically for inhalation lung delivery. It develops inhaled treatments for serious lung infections. The proprietary liposomal technology is designed specifically for delivery of pharmaceuticals to the lung, and it provides for potential improvements to the conventional inhalation methods of delivering drug to the pulmonary system. The company focuses on markets with high unmet medical needs, orphan markets, which present a significant opportunity. Its main product is IPLEX, which is a complex of recombinant human IGF-1 and its binding protein IGFBP-3, is being studied as a treatment for several serious medical conditions. Insmed was founded on November 29, 1999 and is headquartered in Monmouth Junction, NJ.
Similar to: GW Pharmaceuticals Plc, Apricus Biosciences, Inc., AstraZeneca Plc
Featured Company
Aberdeen Private Equity Fund Ltd.
London, Guernsey , GG
**Objective of Aberdeen Private Equity Fund** The investment objective of the Company is to generate long-term capital gains. … Learn more →
Social Monitor
You may also be interested in:
AstraZeneca Plc
London, LO, GB
AstraZeneca Plc is a global research-based biopharmaceutical company, which discovers, develops and markets medicines for gastrointestinal,… Learn more →
Apricus Biosciences, Inc.
San Diego, CA, US
Apricus Bio, a San Diego based revenue-generating pharmaceutical company, has leveraged the flexibility of its clinically-validated… Learn more →
GW Pharmaceuticals Plc
Salisbury, WI, GB
GW Pharmaceuticals Plc researches and develops cannabinoid medicines. The companys principal activity is developing and manufacturing… Learn more →